Zynerba Pharmaceuticals Inc (ZYNE)

0.856
-0.044(-4.92%)
After Hours
0.891
+0.035(+4.125%)
- Real-time Data
  • Volume:
    1,218,563
  • Day's Range:
    0.836 - 1.010
  • 52 wk Range:
    0.840 - 6.070

ZYNE Overview

Prev. Close
0.856
Day's Range
0.836-1.01
Revenue
-
Open
0.95
52 wk Range
0.84-6.07
EPS
-0.93
Volume
1,218,563
Market Cap
36.48M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
323,429
P/E Ratio
-
Beta
2.27
1-Year Change
-80.81%
Shares Outstanding
42,636,631
Next Earnings Date
May 16, 2022
What is your sentiment on Zynerba Pharma?
or
Market is currently closed. Voting is open during market hours.

Zynerba Pharmaceuticals Inc News

Zynerba Pharmaceuticals Inc Company Profile

Zynerba Pharmaceuticals Inc Company Profile

Employees
28

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell